Open Nav

NAPIGEN, INC.

  • Hajime Sakai, NAPIGEN, INC.

Biotechnology company that uses genome engineering to develop a hybridization technology targeting the energy-producing organelles in plants and animals and subsequently producing hybrid crop plants that increase yields. This technology allows for the production of non-GM hybrid seeds in plants that are commonly non-hybrid in an effort to address food supply demands.

  • Date:Tuesday, July 9
  • Time:1:15 PM - 1:30 PM
  • Room:Booth 400
  • Location:Booth 400, Exhibition Hall
  • Session Type:Start-Up Stadium
Speakers
Hajime Sakai
NAPIGEN, INC.
Back